2022
DOI: 10.1007/s00018-022-04340-z
|View full text |Cite
|
Sign up to set email alerts
|

PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 43 publications
0
1
0
Order By: Relevance
“…SERPINE1 may play a role in neurodegeneration/neuroprotection via extracellular matrix remodelling, excitotoxicity, blood-brain barrier opening, and recruitment and activation of microglia [30], while secretion of SERPINE2 by astroglia/oligodendroglia at the axoglial junction is believed to regulate nodal length and myelin structure in the optic nerve and corpus callosum [13]. Aberrant expression of SERPINE1 has been linked to neurodegenerative diseases, including Alzheimer’s [1, 27], Parkinson’s disease [57], and MS [28]. Serpinopathies, e.g., ALS (with SERPINE2 accumulation), are characterized by neuronal inclusion bodies that accumulate within the ER and elicit an ER overload response and cell death signalling, [10, 30, 43, 52].…”
Section: Discussionmentioning
confidence: 99%
“…SERPINE1 may play a role in neurodegeneration/neuroprotection via extracellular matrix remodelling, excitotoxicity, blood-brain barrier opening, and recruitment and activation of microglia [30], while secretion of SERPINE2 by astroglia/oligodendroglia at the axoglial junction is believed to regulate nodal length and myelin structure in the optic nerve and corpus callosum [13]. Aberrant expression of SERPINE1 has been linked to neurodegenerative diseases, including Alzheimer’s [1, 27], Parkinson’s disease [57], and MS [28]. Serpinopathies, e.g., ALS (with SERPINE2 accumulation), are characterized by neuronal inclusion bodies that accumulate within the ER and elicit an ER overload response and cell death signalling, [10, 30, 43, 52].…”
Section: Discussionmentioning
confidence: 99%
“…Experimental models show the importance of PAI-1 (overexpressed by reactive astrocytes leading dysfibrinolysis in MS). (Lebas H, et al [3]) Further studies should be performed to evaluate the role of PAI mutation in MS patients and also for vascular diseases. The thrombotic risk factors associated with MS such as obesity, smoking, endothelial dysfunction, platelet activation, thrombophilia are pro-thrombotic conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Fibrin(ogen) deposits, usually degraded by the PAS, lead an autoimmune response and following demyelination. However, the PAS disruption is not well understood in this disorder [9,10]. Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) because of genetic and environmental factors.…”
Section: Introductionmentioning
confidence: 99%